SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009646
Filing Date
2020-08-06
Accepted
2020-08-06 16:08:12
Documents
70
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ymab-20200630x10q.htm   iXBRL 10-Q 1737902
2 EX-31.1 ymab-20200630xex31d1.htm EX-31.1 15707
3 EX-31.2 ymab-20200630xex31d2.htm EX-31.2 13912
4 EX-32.1 ymab-20200630xex32d1.htm EX-32.1 7767
5 EX-32.2 ymab-20200630xex32d2.htm EX-32.2 7724
  Complete submission text file 0001558370-20-009646.txt   5903988

Data Files

Seq Description Document Type Size
6 EX-101.SCH ymab-20200630.xsd EX-101.SCH 49773
7 EX-101.CAL ymab-20200630_cal.xml EX-101.CAL 33360
8 EX-101.DEF ymab-20200630_def.xml EX-101.DEF 175279
9 EX-101.LAB ymab-20200630_lab.xml EX-101.LAB 422210
10 EX-101.PRE ymab-20200630_pre.xml EX-101.PRE 342740
11 EXTRACTED XBRL INSTANCE DOCUMENT ymab-20200630x10q_htm.xml XML 775711
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38650 | Film No.: 201081632
SIC: 2834 Pharmaceutical Preparations